Laurion Capital Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,293,686
| Closed | -$823K | – | 290 |
|
|
2025
Q1 | $823K | Buy |
1,293,686
+45,322
| +4% | +$28.8K | 0.02% | 97 |
|
|
2024
Q4 | $1.29M | Hold |
1,248,364
| – | – | 0.02% | 86 |
|
|
2024
Q3 | $1.47M | Sell |
1,248,364
-278,023
| -18% | -$328K | 0.02% | 91 |
|
|
2024
Q2 | $1.86M | Buy |
1,526,387
+762,200
| +100% | +$930K | 0.02% | 125 |
|
|
2024
Q1 | $1.67M | Sell |
764,187
-329,734
| -30% | -$719K | 0.01% | 180 |
|
|
2023
Q4 | $1.7M | Sell |
1,093,921
-94,304
| -8% | -$146K | 0.01% | 119 |
|
|
2023
Q3 | $1.53M | Hold |
1,188,225
| – | – | 0.01% | 129 |
|
|
2023
Q2 | $2.04M | Hold |
1,188,225
| – | – | 0.01% | 100 |
|
|
2023
Q1 | $1.79M | Sell |
1,188,225
-82,675
| -7% | -$125K | 0.01% | 106 |
|
|
2022
Q4 | $2.03M | Hold |
1,270,900
| – | – | 0.01% | 111 |
|
|
2022
Q3 | $1.84M | Hold |
1,270,900
| – | – | 0.01% | 137 |
|
|
2022
Q2 | $2.33M | Buy |
+1,270,900
| New | +$2.33M | 0.04% | 109 |
|